Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Identification and functional analysis of a novel human CYP2E1 far upstream enhancer. Mol Pharmacol 2007 Jun;71(6):1630-9

Date

03/14/2007

Pubmed ID

17353354

DOI

10.1124/mol.106.031302

Scopus ID

2-s2.0-34347338782 (requires institutional sign-in at Scopus site)   11 Citations

Abstract

Both transcriptional and post-transcriptional CYP2E1 regulatory mechanisms are known, resulting in 20-fold or greater variation in CYP2E1 expression. To evaluate functional regulatory elements controlling transcription, CYP2E1 promoter constructs were used to make adenovirus vectors containing CYP2E1 promoter-driven luciferase reporters for analyses in both primary human hepatocytes and HepG2 cells. A 1.2-kilobase pair portion of the CYP2E1 promoter was associated with 5- to 10-fold greater luciferase activity. This upstream region contained five direct repeats of 59 base pairs (bp) that increased thymidine kinase-driven luciferase reporter activity in HepG2 cells more than 5-fold, regardless of orientation. Electrophoretic mobility shift assays (EMSAs) identified sequence-specific nuclear protein binding to the 59-bp repeats that was dependent on a 17-bp sequence containing a canonical GATA binding site (WGATAR). Competitive and supershift EMSA identified the participation of GATA4, another GATA family member or GATA-like factor, and a third factor unrelated to the GATA family. Involvement of the tricho-rhino-phalangeal syndrome-1 factor, which also binds a GATA sequence, was eliminated. Rather, competitive EMSA using known binding sequences for the orphan nuclear receptors, steroidogenic factor-1 (or NR5A1), and fetoprotein transcription factor (or NR5A2) implicated an NR5A member in binding a sequence overlapping the canonical GATA. Chromatin immunoprecipitation assay demonstrated in vivo binding of NR5A2 to the enhancer sequence in human hepatocytes. The enhancer sequence is conserved within the human population but seems species-specific. The identification of this novel enhancer and its putative mechanism adds to the complexities of human CYP2E1 regulation.

Author List

Shadley JD, Divakaran K, Munson K, Hines RN, Douglas K, McCarver DG



MESH terms used to index this publication - Major topics in bold

Base Sequence
Binding Sites
Cells, Cultured
Cytochrome P-450 CYP2E1
Enhancer Elements, Genetic
GATA4 Transcription Factor
Gene Expression Regulation, Enzymologic
Genetic Variation
Hepatocytes
Humans
Molecular Sequence Data
Promoter Regions, Genetic
Repetitive Sequences, Nucleic Acid
Steroidogenic Factor 1
Trans-Activators
Transcriptional Activation